Towa International Email Format
Pharmaceutical ManufacturingCatalonia, Spain501-1000 Employees
Towa International serves as the international arm of Towa Pharmaceutical, conducting research, development, manufacture, and marketing of generic medicines and value-added therapies to support public health. Based in Barcelona, Catalonia, Spain, it markets directly in Europe and the United States and extends its reach to more than 60 countries through strategic alliances. The business operates through three units that function independently while complementing each other: Breckenridge Pharmaceutical in the U.S., Towa Europe covering Italy, Spain, and Portugal, and Towa 2B for worldwide activities. Operating in the pharmaceutical manufacturing sector, the company concentrates on delivering medicines that address clinical needs, alongside initiatives aimed at improving patient access through its distribution network. In December 2025, reports noted a recall of duloxetine delayed-release capsules marketed as a generic version of Cymbalta, reflecting a concrete product issue associated with its operations.